0001209191-18-044758.txt : 20180801 0001209191-18-044758.hdr.sgml : 20180801 20180801165651 ACCESSION NUMBER: 0001209191-18-044758 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180730 FILED AS OF DATE: 20180801 DATE AS OF CHANGE: 20180801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Broadfoot Jill Marie CENTRAL INDEX KEY: 0001305178 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37378 FILM NUMBER: 18985483 MAIL ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER NAME: FORMER CONFORMED NAME: Church Jill Marie DATE OF NAME CHANGE: 20041005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: aTYR PHARMA INC CENTRAL INDEX KEY: 0001339970 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203435077 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-731-8389 MAIL ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-07-30 0 0001339970 aTYR PHARMA INC LIFE 0001305178 Broadfoot Jill Marie 3545 JOHN HOPKINS COURT, SUITE 250 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Employee Stock Option (right to buy) 0.8151 2018-07-30 4 A 0 200000 0.00 A 2028-07-30 Common Stock 200000 200000 D 1/4 of the shares subject to this option shall vest and become exercisable on July 30, 2018, and the remainder shall thereafter vest and become exercisable in 36 equal monthly installments, such that this option will be fully exercisable on July 30, 2022. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Nancy D. Krueger, attorney-in-fact 2018-08-01